New Enterprise Associates 16, L.P.
CIK 0001694560
Director10% Owner
Filings
7
Latest Oct 6, 2025
Issuers covered
5
Showing
7 of 7
Page 1
Track record
2 of 5 open-market trades scored (40% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -32.0% | -32.0% | -27.2% | -36.8% |
| 90 days | 2 | 50% | -15.7% | -15.7% | +31.3% | -62.6% |
| 180 days | 2 | 0% | -47.3% | -47.3% | -36.0% | -58.5% |
| 365 days | 2 | 0% | -46.6% | -46.6% | -32.7% | -60.5% |
Issuers
Companies where New Enterprise Associates 16, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BHG | Bright Health Group Inc. | 3 | Oct 6, 2025 |
| GNCA | Genocea Biosciences, Inc. | 1 | May 26, 2022 |
| MRKR | Marker Therapeutics, Inc. | 1 | Dec 23, 2024 |
| MIRM | Mirum Pharmaceuticals, Inc. | 1 | Jun 15, 2023 |
| TRVI | Trevi Therapeutics, Inc. | 1 | Apr 13, 2022 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|